Tag: FAIN
Canadian Syncope Risk Score Validated Internationally
CSRS has good performance for identifying patients with syncope at low risk for serious outcomes
Midodrine Cuts Recurrent Syncope in Young, Healthy Patients
Absolute risk reduced by 19 percentage points, with number needed to treat to prevent syncope of 5.3
Anxiety-Related Adverse Event Clusters ID’d After Janssen Vaccine
Rate of syncope was 8.2 per 100,000 doses after Janssen COVID-19 vaccination versus 0.05 per 100,000 after flu shots
